GENETIC ANALYSIS NK -60 (8V8) — Defensive Interval Ratio

Latest as of June 2026: 19 days

GENETIC ANALYSIS NK -60 (8V8) has a Defensive Interval Ratio of 19 days as of June 2026. Defensive assets of €825.00K (cash €-, short-term investments €-, receivables €825.00K) cover 19 days of daily cash needs of €44.19K/day.

Defensive Interval Ratio

19 days
Days of operational coverage

Defensive Assets

€825.00K
Cash + ST Investments + Receivables

Daily Cash Need

€44.19K
Current Liabilities ÷ 365

Current Liabilities

€16.13 Million
EUR

GENETIC ANALYSIS NK -60 Defensive Interval Ratio (2021–2025)

This chart shows how GENETIC ANALYSIS NK -60's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at 19 days, meaning defensive assets of €825.00K can fund 19 days of operations without new revenue. For the complete balance sheet picture, see GENETIC ANALYSIS NK -60 total assets.

Annual Defensive Interval Ratio for GENETIC ANALYSIS NK -60 (2021–2025)

The table below presents the year-by-year Defensive Interval Ratio for GENETIC ANALYSIS NK -60 from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See 8V8 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2025 37 days €1.91 Million €51.96K/day €- €- ▼ -62 days
2024 99 days €3.20 Million €32.44K/day €- €- ▲ +55 days
2023 43 days €1.90 Million €43.96K/day €- €- ▼ -30 days
2022 74 days €2.61 Million €35.47K/day €- €- ▲ +35 days
2021 38 days €1.05 Million €27.31K/day €- €-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)